230 ECHOCARDIOGRAPHY EDUCATION CONFERENCE "VSD & Pericarditis, Pericarditis, TEE and Endocarditis " (032322)

Dallas, TX US
March 23, 2022

Utilizing a multidisciplinary approach, this series is designed to assist participants in distinguishing the importance of treatment regimens by reviewing translational research as it relates to the ongoing treatment of benign and malignant tumors of the central nervous system (CNS).

Target Audience

UT Southwestern Physicians, Residents, Fellows, Community Physicians, and Nurses.

Learning Objectives

At the conclusion of this activity, participants should be able to:
1. Associate how ongoing review of translational research is related to current treatment of benign and malignant tumors of the CNS.
2. Describe the different treatment options for patient who cannot tolerate first line treatment of chemotherapy and radiation.
3. Recognize the importance of expediting the treatment program for recently diagnosed malignant tumors.

Course summary
Available credit: 
  • 1.00 AMA
  • 1.00 Attendance
Course opens: 
03/23/2022
Course expires: 
03/23/2022
Event starts: 
03/23/2022 - 4:30pm CDT
Event ends: 
03/23/2022 - 5:30pm CDT
Cost:
$0.00
UT Southwestern Medical Center
5171 Harry Hines Blvd.
Meadows Conference Room
Dallas, TX 75235
United States
Course Director(s)

Ravi Joshi, Medical Doctor (M.D.) , Fellow of the American Society of Echocardiography (FASE)

has a financial relationship (Financial Stake) with ROMTech ;.
Peer reviewer(s)

Amanda Fox

has no relevant financial relationships to disclose at this time.
Speaker(s)

Ravi Joshi, Medical Doctor (M.D.) , Fellow of the American Society of Echocardiography (FASE)

has a financial relationship (Financial Stake) with ROMTech ;.

Randy Mielke

has no relevant financial relationships to disclose at this time.

Jason Smith, MD

has no relevant financial relationships to disclose at this time.

Available Credit

  • 1.00 AMA
  • 1.00 Attendance

Price

Cost:
$0.00
Please login or create an account to take this course.